Waters Corporation

Aim is to Support the Drug Control Centre's Efforts to Develop Novel Analytical Methods for Sports Drug Testing and Toxicological Studies

Waters and University of Warwick Sign Research Agreement Designed to Foster Adoption of Novel MS Technologies

MILFORD, Massachusetts, November 10, 2010 - Waters Corporation (NYSE: WAT) today welcomed into its Centers of Innovation Program the Drug Control Centre within the Department of Forensic Science and Drug Monitoring at King's College London.

MORE..

Older News

MILFORD, Massachusetts - Centerpiece of the is the establishment of The Waters Centre for BioMedical Mass Spectrometry Waters Corporation (NYSE: WAT) and the University of Warwick, Coventry and Warwickshire, England, today signed a collaborative research agreement intended to support the growth, development and adoption of novel mass spectrometry (MS) technologies, including Waters(R) SYNAPT High Definition MS(TM) (HDMS(TM)) system.

MORE..